Alberta Investment Management Corp (AIMCo)’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-49,730
| Closed | -$4.24M | – | 679 |
|
|
2025
Q4 | $4.24M | Sell |
49,730
-18,570
| -27% | -$1.52M | 0.03% | 386 |
|
|
2025
Q3 | $5.31M | Buy |
+68,300
| New | +$5.34M | 0.04% | 253 |
|
|
2024
Q4 | – | Sell |
-94,238
| Closed | -$6.22M | – | 821 |
|
|
2024
Q3 | $6.22M | Hold |
94,238
| – | – | 0.05% | 210 |
|
|
2024
Q2 | $8.7M | Sell |
94,238
-13,600
| -13% | -$1.2M | 0.09% | 161 |
|
|
2024
Q1 | $10.3M | Hold |
107,838
| – | – | 0.1% | 161 |
|
|
2023
Q4 | $8.22M | Hold |
107,838
| – | – | 0.08% | 174 |
|
|
2023
Q3 | $7.47M | Hold |
107,838
| – | – | 0.08% | 219 |
|
|
2023
Q2 | $10.2M | Sell |
107,838
-53,970
| -33% | -$4.69M | 0.1% | 199 |
|
|
2023
Q1 | $13.4M | Sell |
161,808
-5,427
| -3% | -$427K | 0.13% | 166 |
|
|
2022
Q4 | $12.5M | Sell |
167,235
-44,198
| -21% | -$3.41M | 0.11% | 203 |
|
|
2022
Q3 | $17.5M | Sell |
211,433
-13,029
| -6% | -$1.25M | 0.13% | 152 |
|
|
2022
Q2 | $21.3M | Buy |
224,462
+30,010
| +15% | +$3.11M | 0.15% | 137 |
|
|
2022
Q1 | $22.9M | Sell |
194,452
-31,252
| -14% | -$3.51M | 0.13% | 167 |
|
|
2021
Q4 | $29.2M | Hold |
225,704
| – | – | 0.18% | 123 |
|
|
2021
Q3 | $25.6M | Hold |
225,704
| – | – | 0.22% | 102 |
|
|
2021
Q2 | $23.4M | Sell |
225,704
-423
| -0.2% | -$39.9K | 0.19% | 116 |
|
|
2021
Q1 | $18.9M | Buy |
226,127
+25,168
| +13% | +$2.13M | 0.17% | 136 |
|
|
2020
Q4 | $18.3M | Sell |
200,959
-29,456
| -13% | -$2.44M | 0.16% | 137 |
|
|
2020
Q3 | $18.4M | Sell |
230,415
-12,900
| -5% | -$1.01M | 0.2% | 114 |
|
|
2020
Q2 | $16.8M | Sell |
243,315
-5,655
| -2% | -$402K | 0.2% | 107 |
|
|
2020
Q1 | $15.7M | Sell |
248,970
-92,148
| -27% | -$6.65M | 0.28% | 83 |
|
|
2019
Q4 | $26.5M | Buy |
341,118
+82,218
| +32% | +$6.42M | 0.22% | 111 |
|
|
2019
Q3 | $19M | Sell |
258,900
-600
| -0.2% | -$42.1K | 0.18% | 131 |
|
|
2019
Q2 | $16M | Buy |
259,500
+7,500
| +3% | +$454K | 0.15% | 147 |
|
|
2019
Q1 | $16.1M | Hold |
252,000
| – | – | 0.15% | 148 |
|
|
2018
Q4 | $12.9M | Sell |
252,000
-64,392
| -20% | -$3.26M | 0.14% | 159 |
|
|
2018
Q3 | $18.4M | Sell |
316,392
-16,608
| -5% | -$812K | 0.16% | 147 |
|
|
2018
Q2 | $16.2M | Hold |
333,000
| – | – | 0.14% | 161 |
|
|
2018
Q1 | $15.5M | Hold |
333,000
| – | – | 0.14% | 173 |
|
|
2017
Q4 | $12.5M | Sell |
333,000
-31,500
| -9% | -$1.16M | 0.11% | 194 |
|
|
2017
Q3 | $13.3M | Buy |
364,500
+31,500
| +9% | +$1.2M | 0.12% | 177 |
|
|
2017
Q2 | $13.1M | Sell |
333,000
-150,000
| -31% | -$5.48M | 0.12% | 179 |
|
|
2017
Q1 | $15.1M | Sell |
483,000
-72,000
| -13% | -$2.25M | 0.13% | 159 |
|
|
2016
Q4 | $17.3M | Sell |
555,000
-16,500
| -3% | -$535K | 0.16% | 142 |
|
|
2016
Q3 | $23M | Sell |
571,500
-12,000
| -2% | -$452K | 0.23% | 114 |
|
|
2016
Q2 | $19.4M | Buy |
583,500
+20,400
| +4% | +$698K | 0.22% | 108 |
|
|
2016
Q1 | $16.6M | Sell |
563,100
-126,900
| -18% | -$3.5M | 0.22% | 100 |
|
|
2015
Q4 | $18.2M | Buy |
690,000
+495,504
| +255% | +$12.9M | 0.21% | 96 |
|
|
2015
Q3 | $4.61M | Buy |
+194,496
| New | +$4.69M | 0.05% | 348 |
|
|
2015
Q1 | – | Sell |
-95,400
| Closed | -$2.02M | – | 526 |
|
|
2014
Q4 | $2.02M | Sell |
95,400
-257,400
| -73% | -$5.17M | 0.02% | 441 |
|
|
2014
Q3 | $6.01M | Hold |
352,800
| – | – | 0.06% | 328 |
|
|
2014
Q2 | $5.05M | Buy |
+352,800
| New | +$4.78M | 0.05% | 351 |
|
Other funds holding EW
Alberta Investment Management Corp (AIMCo)'s EW Position: Q1 2026 in Review
Alberta Investment Management Corp (AIMCo) sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 49,730 shares — an estimated $4.24M sold.
Alberta Investment Management Corp (AIMCo) first reported a position in EW in Q2 2014 and held it in 42 quarters. The position peaked at $29.2M in Q4 2021. 1,292 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Alberta Investment Management Corp (AIMCo) reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
- Alberta Investment Management Corp (AIMCo) sold 49,730 Edwards Lifesciences shares in Q1 2026, an estimated $4.24M.
- Alberta Investment Management Corp (AIMCo) first reported a position in Edwards Lifesciences in Q2 2014 and held it in 42 quarters.
- Alberta Investment Management Corp (AIMCo)'s Edwards Lifesciences position peaked at $29.2M in Q4 2021.
- 1,292 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2026, filed 29 Apr 2026.